Skip to content

Drug interactions

Clorazepate + Lenacapavir

Severity: Moderate

Clorazepate and Lenacapavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor that may raise exposure to the active metabolite of clorazepate, causing prolonged sedation and psychomotor impairment. The inhibitory effect may persist for months after the last subcutaneous dose.

What this interaction means in plain words

Clorazepate and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clorazepate belongs to Central Nervous System; Lenacapavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated metabolism of nordiazepam by lenacapavir.

What to do

Monitor for oversedation and consider reducing the clorazepate dose during and after lenacapavir therapy. Counsel patients on impairment of alertness.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clorazepate and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Clorazepate with Lenacapavir?

MediHelp rates the interaction as moderate. Clorazepate and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor that may raise exposure to the active metabolite of clorazepate, causing prolonged sedation and psychomotor impairment. The inhibitory effect may persist for months after the last subcutaneous dose.

How serious is the interaction between Clorazepate and Lenacapavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for oversedation and consider reducing the clorazepate dose during and after lenacapavir therapy. Counsel patients on impairment of alertness.

What other medicines interact with Clorazepate?

MediHelp also lists interactions of Clorazepate with, for example, Calcium / magnesium / potassium / sodium oxybates, Sodium oxybate, Alfentanil. The full list is on the Clorazepate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in